News Archives - Page 3 of 3 - Irrus Investments

Nexvet Biopharma and Zenoaq R&D Agreement

2018-08-01T14:56:28+01:00

Zenoaq - Research and Development Agreement with Nexvet Please link to the pdf below which was published in July 2015 by zenoaq.jp website. Zenoaq are a Japanese company who are involved in the development, manufacturing, import, export and sales of veterinary pharmaceuticals, biologics and medical devices. In July 2015 Zenoaq announced that it has signed a Research and Development Agreement with Nexvet Biopharma (Ireland) to develop a number of therapeutic biologics for companion animals. You can read the full articles by clicking on the buttons below. Zenoaq Announcement - "Zenoaq and Nexvet Enter Research and Development Collaboration" [...]

Nexvet Biopharma and Zenoaq R&D Agreement2018-08-01T14:56:28+01:00

Wattics Partnership with French Energy Firm CertiNergy

2018-08-01T14:51:35+01:00

The Business Post and UCDinnovation Please link to the articles below which were posted in June 2015 by businesspost.ie and ucd.ie/innovation website. Wattics are an Irrus Investments backed cloud-based energy analytics company. They are a University College Dublin spin-out company which sells unique software for energy management. Wattics have announced a partnership with CertiNergy, a Paris based energy services company. Through this partnership Wattics and CertiNergy will develop a new class of self-learning analytical energy management tools to empower CertiNergy staff manage its thousands of sites throughout Europe in real-time. You can read the full articles by clicking on the [...]

Wattics Partnership with French Energy Firm CertiNergy2018-08-01T14:51:35+01:00

DLA Piper represented Nexvet Biopharma in IPO

2018-08-01T14:37:43+01:00

DLA Piper - advises on Nexvet Biopharma IPO Please link to the article below which was posted in Feb 2015 by dlapiper.com website. In further news on Nexvet Biopharma, the Irish biopharmaceutical company which focuses on the health of companion animals, DLA Piper announced that it represented the company in it's US$40m IPO. You can read the full article by clicking on the button below. DLA Piper News - "DLA Piper advises on Nexvet Biopharma IPO"

DLA Piper represented Nexvet Biopharma in IPO2018-08-01T14:37:43+01:00

Adama Innovations Secures €750,000 Investment

2018-08-01T14:31:35+01:00

The Irish Times - article by Dick Ahlstrom Please link to the article below which was posted in Nov 2014 by theirishtimes.com website. Irrus Investments along with Enterprise Ireland and NDRC VentureLab have provided the seed-funding of €750,000 to this nanotech start-up. Adama Innovations Ltd was formed after a research discovery, relating to the most powerful kind of telescope, was made at Trinity College Dublin. The funding is to enable the company to scale up production in order to drop the cost and appeal to a larger market. You can read the full article by clicking on the button below. [...]

Adama Innovations Secures €750,000 Investment2018-08-01T14:31:35+01:00

Embo Medical Secures €3m Investment

2018-08-01T14:22:07+01:00

KTI - Knowledge Transfer Ireland Please link to the article below which was posted in 2014 by knowledgetransferireland.com website. Irrus Investments are one of a number of backers of Embo Medical, based in NUI Galway's Business Innovation Centre. Embo Medical are an early stage medical device company, they develop technology to treat diseased peripheral vessels or to shut down blood flow in these vessels. The €3m seed funding is to enable Embo Medical secure regulatory approval in order to enter the market and also aims to employ 10 people directly and another 10 indirectly. You can read the full article [...]

Embo Medical Secures €3m Investment2018-08-01T14:22:07+01:00

Sigmoid Pharma raises €5m

2018-08-01T14:14:12+01:00

FirstWord Pharma - referenced from The Irish Times Please link to the article below which was posted in Sept 2014 by firstwordpharma.com website. The post refers to an Irish Times article reporting that Sigmoid Pharma entered into an exclusive licence agreement with Pendopharm to commercialise its product to treat ulcerative colitis. The agreement amounts to a €5m investment. You can read the full article by clicking on the button below. FirstWord Pharma Article - "Sigmoid Pharma raises €5m investment from Pendopharm"

Sigmoid Pharma raises €5m2018-08-01T14:14:12+01:00

Silicon Republic Article – Irish Start-up selected by Facebook

2018-08-01T14:12:13+01:00

Silicon Republic Article by John Kennedy Please link to the article below which was posted in May 2014 by the siliconrepublic.com website. It reports how an Irish software start-up known as Betapond, which received €2.2M in funding from an Ulster Bank led Diago Venture Fund, was selected by Facebook to complete a pilot programme at Facebook's HQ in California. Betapond, who are backed by Irrus Investments, have rebranded as StitcherAds and the pilot programme is known as 'Preferred Marketing Developer Ads Incubator'. You can read the full article by clicking on the button below. Silicon Republic Article - "Betapond [...]

Silicon Republic Article – Irish Start-up selected by Facebook2018-08-01T14:12:13+01:00

The Australian – Nexvet Investment

2018-08-01T14:10:23+01:00

The Australian - Nexvet raises $US31.5m Please link to the article below which was posted in Apr 2014 by theaustralian.com.au website. Nexvet, founded in 2010 and headquartered in Tullamore, Ireland, is a biologic therapeutics company with therapies being developed for companion animals. The company has research and development operations in Melbourne, Australia, a manufacturing facility in Tullamore. The articles reports a significant investment from US-based institutional investors and existing shareholders to advance its clinical programs. You can read the full article by clicking on the button below. The Australian Article - "Nexvet raises $US31.5m" [...]

The Australian – Nexvet Investment2018-08-01T14:10:23+01:00

Irish Independent Article – Sigmoid Pharma

2018-08-01T14:08:39+01:00

Irish Independent - Business Article by Roisin Burke Please link to the article below which was posted in Apr 2014 by independent.ie website. It reports how Sigmoid Pharma is considering a €30m Nasdaq float over the next 12 months. Sigmoid Pharma develop potentially ground-breaking biotech products and is backed by Irrus Investments and Glen Dimplex founder Martin Naughton among others. You can read the full article by clicking on the button below. Irish Independent Business Article - "Sigmoid planning $30m Nasdaq float"

Irish Independent Article – Sigmoid Pharma2018-08-01T14:08:39+01:00

HBAN Article – Irrus Business Angel Syndicate

2018-08-01T14:05:54+01:00

HBAN - Halo Business Angel Network Please link to the article below which was posted in Aug 2013 by the HBAN.org website. It outlines how Irrus Investments is seeking to grow membership and increase equity investments to €10M over 2 years. The articles refers to our policy of seeking new members with an interest in investing in high growth potential technology companies and that investors are encouraged to get involved in both due diligence prior to investment and at board level subsequent to investment. You can read the full article by clicking on the button below. HBAN Article - [...]

HBAN Article – Irrus Business Angel Syndicate2018-08-01T14:05:54+01:00